Why are biologic drugs expensive? Will Trump’s plans make them cheaper?
FDA aims to speed biosimilar approvals to increase competition, but experts warn drug prices may not drop quickly.
FDA aims to speed biosimilar approvals to increase competition, but experts warn drug prices may not drop quickly.